Combined treatment with vitamin D3 and antibody agents suppresses secondary heart transplant rejection in the early postoperative period. [electronic resource]
Producer: 20210324Description: 101270 p. digitalISSN:- 1878-5492
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Cholecalciferol -- therapeutic use
- Drug Therapy, Combination
- Female
- Forkhead Transcription Factors -- metabolism
- Graft Rejection -- etiology
- Graft Survival
- Heart Transplantation
- Humans
- Immunologic Memory
- Immunosuppression Therapy
- Intercellular Adhesion Molecule-1 -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Postoperative Complications -- therapy
- T-Lymphocytes, Regulatory -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.